Ens stage renal disease. End-stage renal disease
Conditions
Interventions
Sponsors
Vice Chancellor for Research, Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patient’s satisfaction, hemodialysis for at least 1 month, hemoglobin concentration <10g/dL in at least 2 episode, Erythropoietin use =12000unit per week, no bleeding over past month, no infection resulting admission in past month, vitamin C use, 2 tablet 250mg per week Exclusion criteria: drug intolerance, bleeding during the study, infection resulting admission
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum hemoglobin level. Timepoint: onset, monthly,end of study. Method of measurement: g/dL.;Serum albumin. Timepoint: onset, monthly, end of study. Method of measurement: g/dL.;Erythropoietin use. Timepoint: monthly. Method of measurement: International unit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total iron binding capacity. Timepoint: Baseline, 3rd month, at the end of study. Method of measurement: µg/dL.;Serum Iron level. Timepoint: Baseline, 3rd month, at the end of study. Method of measurement: µg/dL. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mojgan Mortazavi
Isfahan University of Medical Science
Outcome results
None listed